Search - tctmd.com

Displaying 201 - 220 of 8325

Sort: Relevancy | Date

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

Hybrid/Guide Extension Reverse CART

Presenter: Alfredo R. Galassi, Masahiko Ochiai, Paul Knaapen

November 01, 2016

Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

A Critical Review of Technique Across the Absorb Trials

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman

November 01, 2016

Presentation TCT 2016

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik

November 01, 2016

Presentation TCT 2016

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Presenter: Bernard De Bruyne, Allen Jeremias

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Presentation TCT 2016

Contemporary Reverse CART

Presenter: Alfredo R. Galassi, Masahiko Ochiai, Masahisa Yamane

November 01, 2016

Presentation TCT 2016

European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno

November 01, 2016

Presentation TCT 2016

Standardization of FFR Acquisition and Storage

Presenter: Bernard De Bruyne, Allen Jeremias

November 01, 2016

Presentation TCT 2016

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Christoph K. Naber

November 01, 2016

Advertisement

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Hybrid/Guide Extension Reverse CART

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

FFR in the setting of CABG and AS/AVR/TAVR

A Critical Review of Technique Across the Absorb Trials

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Non-Hyperemic Indices: Glossary and Clinical Outcome Data

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Contemporary Reverse CART

European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Standardization of FFR Acquisition and Storage

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content